Back to search

Article

IKAROS facilitates antigen escape in the face of CD19- and CD22-targeted therapies for B-cell acute lymphoblastic leukemia

2024-11-03

Abstract excerpt

<h4>Summary</h4> Relapse due to antigen escape is a major cause of treatment failure for patients with B-cell malignancies following targeted immunotherapies, including CD19- and CD22-directed chimeric antigen receptor T (CAR T) cells. To identify tumor intrinsic factors associated with antigen loss, we performed single-cell analyses on 61 primary patient samples or patient-derived xenografts from patients with B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9a6f14c-055d-5e46-9e34-c6fb7aa5dacf
DOI
10.1101/2024.11.01.621347
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
IKAROS facilitates antigen escape in the face of CD19- and CD22-targeted therapies for B-cell acute lymphoblastic leukemiaDOI 10.1101/2024.11.01.621347
Select a neighboring publication to make it the new centre.